Low Rates of Transition from Subcutaneous to Intravenous Formulation in Patients with Inflammatory Bowel Diseases Treated with Vedolizumab
AMERICAN JOURNAL OF GASTROENTEROLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined